Syndromes induced by cytomegalovirus infection

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages 215-224

  Price, Patricia ^a   Olver, Stuart D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROSIS; CARDITIS; CYTOMEGALOVIRUS; DIABETES MELLITUS; HEPATITIS; IMMUNE DEFICIENCY; INTERSTITIAL PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VIRUS INFECTION;

EID: 0029824694     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0117     Document Type: Article

References (92)

1. Griffiths, P. D., and Grundy, J. E., The status of CMV as a human pathogen. Epidemiol. Infect. 100, 1-15, 1988.
2. Peckham, C. S., Cytomegalovirus in the neonate. J. Antimicrob. Chemother. 23(Suppl. E), 17-21, 1989.
3. Nigro, G., Vitolo, R., Bartmann, U., and Midulla, M., Hepatitis in pre-school children: Prevalent role of cytomegalovirus. Arch. Virol. 4, 268-272, 1992.
4. Drew, W. L., Cytomegalovirus infection in patients with AIDS. J. Infect. Dis. 158, 449-456, 1988.
5. Borisch, B., Jahn, G., Scholl, B. C., Filger-Brillinger, J., Heymer, B., Fleckenstein, B., and Muller-Hermelink, H. K., Detection of human cytomegalovirus DNA and viral antigens in tissues of different manifestations of CMV infection. Virchows Arch. B 55, 93-99, 1988.
6. Grundy, J. E., Shanley, J. D., and Griffiths, P. D., Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 2, 996-999, 1987.
7. Smith, S. D., Cho, C. T., Brahmacupta, N., and Lenahan, M. F., Pulmonary involvement with cytomegalovirus infections in children. Arch. Dis. Child. 52, 441-446, 1977.
8. Meyers, J. D., McGuffin, R. W., Neiman, P. E., Singer, J. W., and Thomas, E. D., Toxicity and efficacy of human leukocyte Interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. J. Infect. Dis. 141, 555-562, 1980.
9. Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchinson, C. A., Kouzarides, T., Martignetti, J. A., et al., Analysis of the protein coding content of the sequence of HCMV strain AD169. Curr. Top. Microbiol. Immunol. 154, 125-133, 1990.
10. Riddell, S. R., and Greenberg, P. D., Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones. Curr. Top. Microbiol. Immunol. 189, 9-34, 1994.
11. 10a. Karlin, S., Mocarski, E. S., and Schachtel, G. A., Molecular evolution of herpes viruses: Genomic and protein sequence comparisons. J. Virol. 68, 1886-1902, 1994.
12. 10b. Rawlinson, W. D., Farrell, H. E., and Barrell, B. G. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol., in press.
13. Grundy, J. E., McKenzie, and Stanley, N. F., Influence of H-2 and non H-2 genes on murine cytomegalovirus infection. Infect. Immunol. 32, 277-286, 1981.
14. Price, P., Gibbons, A. E., and Shellam, G. R., H-2 class I loci determine sensitivity to murine cytomegalovirus replication in macrophages and fibroblasts. Immunogenetics 32, 20-26, 1990.
15. Grundy, J. E., McKeatling, J. A., Ward, P. J., Sanderson, A. R., and Griffiths, P. D., β2-Microglobulin enhances the infectivity of CMV and when bound to the virus enables class 1 HLA-molecules to be used as a virus receptor. J. Gen. Virol. 68, 793-803, 1987.
16. Nowlin, D. M., Cooper, N., and Compton, T., Expression of a human cytomegalovirus receptor correlates with infectibility of cells. J. Virol. 65, 3114-3121, 1991.
17. Price, P., Allcock, R., Coombes, D., Shellam, G. R., and McCluskey, J., MHC proteins and cell surface glycosaminoglycans influence the infection of susceptible cells with murine cytomegalovirus. Immunol. Cell Biol. 73, 308-315, 1995.
18. Scalzo, A. A., Fitzgerald, N. A., Wallace, C. R., Gibbons, A. E., Smart, Y. C., Burton, R. C., and Shellam, G. R., The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex (NKC), is mediated by natural killer cells. J. Immunol. 149, 581-589, 1992.
19. Price, P., Olver, S. D., Gibbons, A. E., Teo, H. K., and Shellam, G. R., Characterisation of thymic involution induced by murine cytomegalovirus infection. Immunol. Cell Biol. 71, 155-165, 1992.
20. Gibbons, A. E., Price, P., and Shellam, G. R., Analysis of haemopoietic stem and progenitor cell populations in cytomegalovirus-infected mice. Blood 86, 473-481, 1995.
21. Carney, W. P., and Hirsch, M. S., Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J. Infect. Dis. 144, 47-54, 1981.
22. Whyte, P. F., Subramaniam, R., and Hudson, J. B., Characterisation of a murine cytomegalovirus-induced immunosuppressive factor. Arch. Virol. 96, 169-183, 1987.
23. Price, P., Winter, J. G., and Shellam, G. R., Analysis of the inflammatory response to murine cytomegalovirus in susceptible mice. Arch. Virol. 106, 35-50, 1989.
24. Van Bruggen, I., Price, P., Robertson, T. A., and Papadimitriou, J. M., Morphological and functional changes during cytomegalovirus replication in murine macrophages. J. Leukocyte Biol. 46, 508-520, 1989.
25. Shanley, J. D., and Pesanti, E. L., Replication of murine cytomegalovirus in lung macrophages: Effect on phagocytosis of bacteria. Infect. Immun. 29, 1152-1159, 1980.
26. Price, P., Eddy, K. S., Papadimitriou, J. M., Faulkner, D., and Shellam, G. R., Genetic determination of cytomegalovirus-induced and age-related cardiopathy in inbred mice. Characterization of the infiltrating cells. Am. J. Pathol. 138, 59-67, 1990.
27. Olver, S. D., Price, P., and Shellam, G. R., Cytomegalovirus hepatitis: Characterisation of the inflammatory infiltrate in resistant and susceptible mice. Clin. Exp. Immunol. 98, 375-381, 1994.
28. Price, P., Olver, S. D., Gibbons, A. E., and Shellam, G. R., B cell activation following murine cytomegalovirus infection: Implications for autoreactivity. Immunology 78, 14-21, 1993.
29. Rizzo, L. V., De Kruyff, R. H., and Umetsu, D. T., Generation of B cell memory and affinity maturation. Induction with Th1 and Th2 T cell clones. J. Immunol. 148, 3733-3739, 1992.
30. Shanley, J. D., Host genetic factors influence murine cytomegalovirus lung infection and interstitial pneumonia. J. Gen. Virol. 65, 2121-2128, 1984.
31. Orange, J. S., Wang, B., Terhorst, C., and Biron, C. S., Requirement for natural killer cell-produced interferonγ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045-1056, 1995.
32. Pavic, I., Polic, B., Crnkovic, I., Lucin, S., and Koszinowski, U. H., Participation of endogenous tumour necrosis factorα in host resistance to cytomegalovirus infection. J. Gen. Virol. 74, 2215-2223, 1993.
33. Shanley, J. D., Goff, E., Debs, R. J., and Forman, S. J., The role of tumour necrosis factor-α in acute murine cytomegalovirus infection in BALB/c mice. J. Infect. Dis. 169, 1088-1091, 1994.
34. Anderson, K. P., Lie, Y. S., Low, M. A. L., and Fennie, E. H., Effects of tumour necrosis factor-α treatment on mortality in marine cytomegalovirus-infected mice. Antiviral Res. 21, 343-355, 1993.
35. Neumann, D. A., Lane, J. R., Allen, G. S., Herskowitz, A., and Rose, N. R., Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis? Clin. Immunol. Immunopathol. 68, 181-190, 1993.
36. van Hoosier, G. L., Giddens, W. E., Gillet, C. S., and Davis, H., Disseminated cytomegalovirus disease in the guinea pig. Lab. Anim. Sci. 35, 81-84, 1985.
37. Aquino-de Jesus, M. J., and Griffith, B. P., Cytomegalovirus infection of immunocompromised guinea pigs: A model for testing antiviral agents in vivo. Antiviral Res. 12, 181-193, 1989.
38. Lucia, H. L., Griffith, B. P., and Hsiung, G. D., Lymphadenopathy during cytomegalovirus-induced mononucleosis in guinea pigs. Arch. Pathol. Lab. Med. 109, 1019-1023, 1985.
39. Miller, S. A., Bia, F. J., Coleman, D. L., Lucia, H. L., Young, K. R., and Root, R. K., Pulmonary macrophage function during experimental cytomegalovirus interstitial pneumonia. Infect. Immun. 47, 211-216, 1985.
40. Fitzgerald, N. A., and Shellam, G. R., Host genetic influences on fetal susceptibility to murine cytomegalovirus after maternal or fetal infection. J. Infect. Dis. 163, 276-281, 1991.
41. Goff, E., Griffith, B. P., and Booss, J., Delayed amplification of cytomegalovirus infection in the placenta and maternal tissues during late gestation. Am. J. Obstet. Gynecol. 156, 1256-1270, 1987.
42. Harrison, C. J., and Myers, M. G., Maternal cell mediated cytolysis of CMV-infected fetal cells and the outcome of pregnancy in the guinea pig. J. Med. Virol. 27, 66-71, 1989.
43. Harrison, C. J., and Burger, R., Low maternal CD4 count at inception of gestational cytomegalovirus (CMV) infection and impaired humoral response: Effect on congenital CMV infection of the guinea pig. Clin. Immunol. Immunopathol. 60, 171-180, 1991.
44. Zheng, Z. M., Lavallee, J. T., Bia, F. J., and Griffith, B. P., Thymic hypoplasia, splenomegaly and immune depression in guinea pigs with neonatal cytomegalovirus infection. Dev. Comp. Immunol. 11, 407-418, 1987.
45. Woolf, N. K., Koehrn, F. J., Harris, J. P., and Richmann, Congenital cytomegalovirus labyrinthitis and sensoneural hearing loss in guinea pigs. J. Infect. Dis. 160, 929-937, 1989.
46. Keithley, E. M., Sharp, P., Woolf, N. K., and Harris, J. P., Temporal sequence of viral antigen expression in the cochlea induced by cytomegalovirus. Acta. Otolaryngol. 106, 46-54, 1988.
47. Harris, J. P., Fan, J. T., and Keithley, E. M., Immunological responses in experimental cytomegalovirus labyrinthitis. Am. J. Otolaryngol. 11, 304-308, 1990.
48. Booss, J., Dann, P. R., Griffith, B. P., and Kim, J. H., Host defense response to cytomegalovirus in the central nervous system. Predominance of the monocyte. Am. J. Pathol. 134, 71-78, 1989.
49. Haagmans, B. L., Stals, F. S., van der Meide, P. H., Bruggeman, C. A., Horzinek, M. C., and Schijns, V. E. C. J., Tumour necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J. Virol. 68, 2297-2304, 1994.
50. Smith, C. B., Griffiths, B. P., and Wei, L. S., Rat cytomegalovirus infection enhances type II collagen arthritis in rats. Arthritis Rheum. 29, 1263-1228, 1986.
51. Koskinen, P., Lemstrom, K., Bruggeman, C., Lautenschlager, Z. I., and Hayry, P., Acute cytomegalovirus infection induces a sub endothelial inflammation (endothelialitis) in the allograft vascular wall: A possible linkage with enhanced allograft arteriosclerosis. Am. J. Pathol. 144, 41-50, 1994.
52. Ustinov, J. A., Lahtinen, T. T., Bruggeman, C. A., Hayry, P. J., and Lautenschlager, I. T., Direct induction of class II molecules by cytomegalovirus in rat heart microvascular endothelial cells is inhibited by ganciclovir (DHPG). Transplantation 58, 1027-1031, 1994.
53. Span, A. H., Grauls, G., Bosman, F., van Boven, C. P., and Bruggeman, C. A., Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis 93, 41-52, 1992.
54. Haagmans, B. L., van den Eertwegh, A. J., Claasen, E., Bruggeman, C. A., Horzinek, M. C., and Schijns, V. E. C. J., Tumour necrosis factor-alpha production during cytomegalovirus infection of immunosuppressed rats. J. Gen. Virol. 75, 779-787, 1994.
55. + cell depletion or CMV infection. Clin. Immunol. Immunopathol. 65, 227-233, 1992.
56. Alcendor, D. J., Barry, P. A., Pratt-Lowe, E., and Luciw, P. A., Analysis of the rhesus cytomegalovirus immediate-early gene promotor. Virology 194, 815-821, 1993.
57. London, W. T., Martinez, A. J., Houff, S. A., Wallen, W. C., Curfman, B. L., Taub, R. G., and Sever, J. L., Experimental congenital disease with simian cytomegalovirus in rhesus monkeys. Teratology 33, 323-331, 1986.
58. Baskin, G. B., Disseminated cytomegalovirus infection in immunodeficient rhesus monkeys. Am. J. Pathol. 129, 345-352, 1987.
59. Vogel, P., Weigler, B. J., Kerr, H., Hendricks, A. G., and Barry, P. A., Seroepidemiological studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab. Anim. Sci. 44, 25-30, 1994.
60. Ten Napel, CHH., Houthoff, H. J., and The, T. H., CMV hepatitis in normal and immune compromised hosts. Liver 4, 184-194, 1984.
61. Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H., and Kawanishi, M., A multivariate analysis of risk factors for hepatocellular carcinogenesis. Hepatology 18, 47-52, 1993.
62. Lautenschalger, I., Hockerstedt, K., Salmela, K., Isoniemi, H., Holmberg, C., Jalanko, H., and Hayry, P., Fine needle aspiration biopsy in the monitoring of liver allografts. Differing cellular findings during rejection and cytomegalovirus infection. Transplantation 50, 798-803, 1990.
63. Abo, T., Ohteki, T., Seki, S., Koyamada, N., Yoshikai, Y., Masuda, T., Rikiishi, H., and Kamagai, K., The appearance of T cells bearing self reactive T cell receptor in the livers of mice injected with bacteria. J. Exp. Med. 174, 417-424, 1991.
64. Bartholamaeus, W. N., O'Donaghue, H. L., Foti, D., Lawson, C. M., Shellam, G. R., and Reed, W. D., Multiple autoantibodies following murine cytomegalovirus infection: Virus distribution and specificity of autoantibodies. Immunology 64, 397-405, 1988.
65. Lawson, C. M., O'Donaghue, H. L., and Reed, W. D., Mouse cytomegalovirus infection induces antibodies which cross react with virus and cardiac myosin: A model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology 75, 513-519, 1992.
66. Gonzalez-Amaro, R., Garcia-Monzon, C., Garcia-Buey, L., Moreno-Otero, R., Alonso, J. L., Yague, E., Pivel, J. P., Lopez-Cabrera, M., Fernadez-Ruiz, E., and Sanchez-Madrid, F., Induction of tumour necrosis factor a production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 79, 841-848, 1994.
67. Shanley, J. D., Biczak, L., and Forman, S. J., Acute murine cytomeglovirus infection induces lethal hepatitis. J. Infect. Dis. 167, 264-269, 1993.
68. Pak, C. Y., Eun, H-M., McArthur, R. G., and Yoon, J-W., Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2, 1-4, 1988.
69. Lohr, J. M., and Oldstone, M. B. A., Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet 2, 644-648, 1990.
70. Jensen, A. B., Rosenberg, A. S., and Notkins, A. L., Pancreatic islet cell damage in children with fatal viral infections. Lancet 2, 354-358, 1980.
71. Nicoletti, F., Scalia, G., Lunette, M., Condorelli, F., Di Mauro, M., Barcellini, W., Stracuzzi, S., Pagano, M., and Peroni, P. L., Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first degree relatives of type 1 (insulin-dependent) diabetic patients. Clin. Immunol. Immunopathol. 55, 139-147, 1990.
72. Hayashi, K., and Fujisaki, Y., Abnormal glucose metabolism in murine cytomegalovirus (MCMV)-infected mice. Microbiol. Immunol. 29, 429-439, 1985.
73. Price, P., Eddy, K. S., Robertson, T. A., Shellam, G. R., and Papadimitriou, J. M., Cytomegalovirus infection of adipose tissues and the development of steatitis in adult mice. J. Exp. Pathol. 71, 557-571, 1990.
74. Freda, P. L., Wardlow, S. L., Brudney, K., and Goland, R. S., Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome: A report of five cases. J. Clin. Endocrinol. Metab. 79, 1540-1545, 1994.
75. 72a. Price, P., Olver, S. D., Silech, M., Nador, T. Z., Yerkovich, S. T., and Wilson, S. G. Adrenalitis and the adrenocortical response of resistant and susceptible mice to murine cytomegalovirus infection. Eur. J. Clin. Invest., in press.
76. Shanley, J. D., and Pesanti, E. L., Murine cytomegalovirus adrenalitis in athymic nude mice. Arch. Virol. 88, 27-35, 1986.
77. Reynolds, R. P., Rahija, R. J., Schenkman, D. I., and Richter, C. B., Experimental murine cytomegalovirus infection in severe combined immunodeficient mice. Lab. Anim. Sci. 43, 291-295, 1993.
78. Melnick, J. L., Adam, E., and DeBakey, M. E., Possible role of cytomegalovirus in atherogenesis. JAMA 263, 2204-2207, 1990.
79. Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T., and Epstein, S. E., Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394, 1994.
80. Dietz, A. J., Cytomegalovirus infection with carditis, hepatitis and anemia. Postgrad. Med. 70, 203-208, 1981.
81. + (helper) T cells in the pathogenesis of marine cytomegalovirus myocarditis. Lab. Invest. 66, 755-761, 1992.
82. Shanley, J. D., and Pesanti, E. L., The relation of viral replication to interstitial pneumonitis in marine cytomegalovirus lung infection. J. Infect. Dis. 151, 454-458, 1985.
83. Price, P., Hopkins, R. M., Teo, H. K., Papadimitriou, J. M., and Shellam, G. R., Modulation of murine cytomegalovirus-induced pneumonitis by immunosuppressive agents or malnutrition. Pathol. Res. Pract. 187, 993-1000, 1990.
84. Shanley, J. D., Pomeroy, C., Via, C. S., and Shearer, G. M., Interstitial pneumonitis during murine cytomegalovirus infection and graft versus host disease: Effect of gancyclovir therapy. J. Infect. Dis. 158(S6), 1391-1394, 1988.
85. Olver, S. D., Price, P., and Karthigasu, K. T., Potentiation of murine cytomegalovirus pneumonitis by antibiotics in clinical use. J. Antimicrob. Chemother. 27, 81-94, 1990.
86. Tanaka, K., Koga, Y., Lu, Y-Y., Zhang, X-Y., Wang, Y., Kimura, G., and Nomoto, K., Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus. J. Clin. Invest. 94, 1019-1025, 1994.
87. Kadima-Nzuji, M., and Craighead, J. E., T-lymphocyte effects on murine cytomegalovirus pulmonary infection. Am. J. Pathol. 137, 907-912, 1990.
88. Reddehase, M. J., Weiland, F., Munch, K., Jonjic, S., Luske, A., and Koszinowski, U. H., Interstitial murine cytomegalovirus pneumonitis after irradiation: Characterisation of cells that limit viral replication during established infection of the lungs. J. Virol. 55, 264-273, 1985.
89. Dix, R. D., Cray, C., and Cousins, S. W., Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis. Curr. Eye Res. 13, 587-595, 1994.
90. Niemialtowski, M. G., and Rouse, B. T., Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149, 3035-3039, 1992.
91. Dunkel, E. C., MCMV-induced chorioretinitis in the rabbit. Transplant. Proc. 23(S3), 25-28, 1991.
92. Narang, H. K., Progression of cytomegalovirus in the rabbit following the intraocular injection of the virus. J. Chemother. 6, 412-416, 1994.